Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.
See more
Current price
€52.24
Original price
€54.99
Save 5%
Delivery/Collection within 10-20 working days
Product Details
Weight: 360g
Dimensions: 123 x 186mm
Publication Date: 16 May 2019
Publisher: Cambridge University Press
Publication City/Country: United Kingdom
Language: English
ISBN13: 9781108447461
About Jonathan M. MeyerStephen M. Stahl
Jonathan M. Meyer is currently a Clinical Professor of Psychiatry at the University of California San Diego and a Psychopharmacology Consultant to the California Department of State Hospitals. Dr Meyer is an internationally recognised speaker on psychopharmacology and the treatment of severe mental illness and is Distinguished Fellow of the American Psychiatric Association. Stephen M. Stahl is currently a Professor at the University of California San Diego and serves as Honorary Fellow in the psychiatry department at the University of Cambridge. He is also the Chairman of the Neuroscience Education Institute (NEI) and Arbor Scientia Group. Dr Stahl serves as the Director of Psychopharmacology Services at the California Department of State Hospitals as well as the Editor-in Chief of CNS Spectrums.